|
Nov 5
|
2 Magnificent Growth Stocks That Might Be Badly Mispriced Right Now
|
|
Nov 3
|
Why CRISPR Therapeutics Stock Charged Northward This Week
|
|
Nov 3
|
CRISPR Therapeutics AG (CRSP) Recently Broke Out Above the 50-Day Moving Average
|
|
Nov 3
|
Here's What Investors Need to Know About Vertex Pharmaceuticals and CRISPR Therapeutics' Big Day at the FDA
|
|
Nov 3
|
3 Healthcare Stocks to Buy Hand Over Fist in November
|
|
Aug 26
|
3 Surprisingly Underrated Stocks to Buy Right Now
|
|
Aug 24
|
Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks
|
|
Aug 22
|
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
|
|
Jun 29
|
This 1 Problem Could Sink at Least 4 Gene-Editing Stocks
|
|
Jun 29
|
Calculating The Intrinsic Value Of CRISPR Therapeutics AG (NASDAQ:CRSP)
|
|
Jun 28
|
2 Under-the-Radar Biotech Stocks to Buy in 2023
|
|
Jun 28
|
The Best Stocks to Invest $20,000 in Right Now
|
|
Jun 27
|
Wall Street Estimates That CRISPR Therapeutics Stock Could Jump 49%. Here's Why That's Right.
|
|
Jun 26
|
CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know
|
|
Jun 25
|
3 Monster Stocks in the Making to Buy Right Now
|
|
Jun 9
|
Crispr Stock Slips; The FDA Could Approve The First CRISPR-Based Gene-Editing Drug In Just Six Months
|
|
Jun 9
|
FDA Accepts Vertex (VRTX), CRISPR's BLA Filings for Exa-Cel
|
|
Jun 9
|
Vertex/CRISPR Partnered Cell Therapy Shows Encouraging Response In Sickle Cell Disease, Thalassemia Patients
|
|
Jun 9
|
Wall Street Loves These 3 Growth Stocks -- Should You?
|
|
Jun 9
|
Positive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Presented at the 2023 Annual European Hematology Association (EHA) Congress
|